Friday, 24 January 2014

Is Ranbaxy a contra buy? Stock slips 19% on USFDA import alert

Ranbaxy Laboratories Ltd plunged as much as 19.90 per cent in trade on Friday, after the US Food and Drug Administration import alert.



from Stocks-Markets-The Economic Times http://ift.tt/1jIKnFY

No comments:

Post a Comment